Q1 confirms Medical's strength without licence income; Lu-177 and IP recovery provide FY26 upside catalysts.
13 May 2026
Q1 released: Medical powers ahead
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Q1 released: Medical powers ahead
Eckert & Ziegler SE (EUZ:ETR) | 0 0 (-1.4%) | Mkt Cap: 188.4m
- Published:
13 May 2026 -
Author:
Simon Keller -
Pages:
11 -
Q1 confirms Medical's strength without licence income; Lu-177 and IP recovery provide FY26 upside catalysts.